Contractile activity modulates atrial natriuretic factor gene expression in neonatal rat ventricular myocytes

Diane M. Eble, Brian M. Cadre, Ming Qi, Donald M Bers, Allen M. Samarel

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

[Ca2+](i) transients, and the activation of Ca2+-sensitive kinases have been considered potential signaling mechanisms regulating ANF gene expression in cultured neonatal rat ventricular myocytes (NRVM). However, it is unclear whether [Ca2+](i) is directly involved, or is indirectly involved by generating additional mechanical signals via contractile activity. Primary cultures of spontaneously contracting NRVM (CON), and NRVM treated for 48 h with verapamil (V, 10 μM), KCl (50 mM), or 2,3-butanedione monoxime (BDM, 7.5 mM) were used to delineate the affects of contractile activity v [Ca2+](i). Verapamil, a calcium channel blocker, inhibits contraction and decreases [Ca2+](i). High [K+](o) causes membrane depolarization, loss of contraction, and elevates [Ca2+](i); whereas BDM strongly inhibits contractile activity but only modestly reduces [Ca2+](i) transients. ANF production, as assessed by radioimmunoassay, was significantly reduced upon contractile arrest independently of [Ca2+](i) levels. Northern blotting analysis demonstrated that contractile arrest also reduced ANF mRNA levels. Transient transfection of a 3003 bp ANF promoter-luciferase expression plasmid in CON, V, KCl, and BDM-treated NRVM demonstrated marked down-regulation of ANF promoter activity in all of the contractile arrested myocytes. These results indicate that the activation of Ca2+-sensitive processes alone are insufficient to maintain high levels of ANF gene expression and peptide production in NRVM.

Original languageEnglish (US)
Pages (from-to)55-60
Number of pages6
JournalJournal of Molecular and Cellular Cardiology
Volume30
Issue number1
DOIs
StatePublished - Jan 1998
Externally publishedYes

Fingerprint

Atrial Natriuretic Factor
Muscle Cells
Gene Expression
Verapamil
Calcium Channel Blockers
Luciferases
Northern Blotting
Radioimmunoassay
Transfection
Plasmids
Phosphotransferases
Down-Regulation
Messenger RNA
Peptides
Membranes

Keywords

  • Calcium
  • Cardiomyocytes
  • Contraction

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Contractile activity modulates atrial natriuretic factor gene expression in neonatal rat ventricular myocytes. / Eble, Diane M.; Cadre, Brian M.; Qi, Ming; Bers, Donald M; Samarel, Allen M.

In: Journal of Molecular and Cellular Cardiology, Vol. 30, No. 1, 01.1998, p. 55-60.

Research output: Contribution to journalArticle

@article{d2404166750847a1972808caea91bc20,
title = "Contractile activity modulates atrial natriuretic factor gene expression in neonatal rat ventricular myocytes",
abstract = "[Ca2+](i) transients, and the activation of Ca2+-sensitive kinases have been considered potential signaling mechanisms regulating ANF gene expression in cultured neonatal rat ventricular myocytes (NRVM). However, it is unclear whether [Ca2+](i) is directly involved, or is indirectly involved by generating additional mechanical signals via contractile activity. Primary cultures of spontaneously contracting NRVM (CON), and NRVM treated for 48 h with verapamil (V, 10 μM), KCl (50 mM), or 2,3-butanedione monoxime (BDM, 7.5 mM) were used to delineate the affects of contractile activity v [Ca2+](i). Verapamil, a calcium channel blocker, inhibits contraction and decreases [Ca2+](i). High [K+](o) causes membrane depolarization, loss of contraction, and elevates [Ca2+](i); whereas BDM strongly inhibits contractile activity but only modestly reduces [Ca2+](i) transients. ANF production, as assessed by radioimmunoassay, was significantly reduced upon contractile arrest independently of [Ca2+](i) levels. Northern blotting analysis demonstrated that contractile arrest also reduced ANF mRNA levels. Transient transfection of a 3003 bp ANF promoter-luciferase expression plasmid in CON, V, KCl, and BDM-treated NRVM demonstrated marked down-regulation of ANF promoter activity in all of the contractile arrested myocytes. These results indicate that the activation of Ca2+-sensitive processes alone are insufficient to maintain high levels of ANF gene expression and peptide production in NRVM.",
keywords = "Calcium, Cardiomyocytes, Contraction",
author = "Eble, {Diane M.} and Cadre, {Brian M.} and Ming Qi and Bers, {Donald M} and Samarel, {Allen M.}",
year = "1998",
month = "1",
doi = "10.1006/jmcc.1997.0571",
language = "English (US)",
volume = "30",
pages = "55--60",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Contractile activity modulates atrial natriuretic factor gene expression in neonatal rat ventricular myocytes

AU - Eble, Diane M.

AU - Cadre, Brian M.

AU - Qi, Ming

AU - Bers, Donald M

AU - Samarel, Allen M.

PY - 1998/1

Y1 - 1998/1

N2 - [Ca2+](i) transients, and the activation of Ca2+-sensitive kinases have been considered potential signaling mechanisms regulating ANF gene expression in cultured neonatal rat ventricular myocytes (NRVM). However, it is unclear whether [Ca2+](i) is directly involved, or is indirectly involved by generating additional mechanical signals via contractile activity. Primary cultures of spontaneously contracting NRVM (CON), and NRVM treated for 48 h with verapamil (V, 10 μM), KCl (50 mM), or 2,3-butanedione monoxime (BDM, 7.5 mM) were used to delineate the affects of contractile activity v [Ca2+](i). Verapamil, a calcium channel blocker, inhibits contraction and decreases [Ca2+](i). High [K+](o) causes membrane depolarization, loss of contraction, and elevates [Ca2+](i); whereas BDM strongly inhibits contractile activity but only modestly reduces [Ca2+](i) transients. ANF production, as assessed by radioimmunoassay, was significantly reduced upon contractile arrest independently of [Ca2+](i) levels. Northern blotting analysis demonstrated that contractile arrest also reduced ANF mRNA levels. Transient transfection of a 3003 bp ANF promoter-luciferase expression plasmid in CON, V, KCl, and BDM-treated NRVM demonstrated marked down-regulation of ANF promoter activity in all of the contractile arrested myocytes. These results indicate that the activation of Ca2+-sensitive processes alone are insufficient to maintain high levels of ANF gene expression and peptide production in NRVM.

AB - [Ca2+](i) transients, and the activation of Ca2+-sensitive kinases have been considered potential signaling mechanisms regulating ANF gene expression in cultured neonatal rat ventricular myocytes (NRVM). However, it is unclear whether [Ca2+](i) is directly involved, or is indirectly involved by generating additional mechanical signals via contractile activity. Primary cultures of spontaneously contracting NRVM (CON), and NRVM treated for 48 h with verapamil (V, 10 μM), KCl (50 mM), or 2,3-butanedione monoxime (BDM, 7.5 mM) were used to delineate the affects of contractile activity v [Ca2+](i). Verapamil, a calcium channel blocker, inhibits contraction and decreases [Ca2+](i). High [K+](o) causes membrane depolarization, loss of contraction, and elevates [Ca2+](i); whereas BDM strongly inhibits contractile activity but only modestly reduces [Ca2+](i) transients. ANF production, as assessed by radioimmunoassay, was significantly reduced upon contractile arrest independently of [Ca2+](i) levels. Northern blotting analysis demonstrated that contractile arrest also reduced ANF mRNA levels. Transient transfection of a 3003 bp ANF promoter-luciferase expression plasmid in CON, V, KCl, and BDM-treated NRVM demonstrated marked down-regulation of ANF promoter activity in all of the contractile arrested myocytes. These results indicate that the activation of Ca2+-sensitive processes alone are insufficient to maintain high levels of ANF gene expression and peptide production in NRVM.

KW - Calcium

KW - Cardiomyocytes

KW - Contraction

UR - http://www.scopus.com/inward/record.url?scp=0031893880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031893880&partnerID=8YFLogxK

U2 - 10.1006/jmcc.1997.0571

DO - 10.1006/jmcc.1997.0571

M3 - Article

VL - 30

SP - 55

EP - 60

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 1

ER -